As of 2024-12-15, the EV/EBITDA ratio of Dexcom Inc (DXCM) is 37.43. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Dexcom's latest enterprise value is 32,027.01 mil USD. Dexcom's TTM EBITDA according to its financial statements is 855.60 mil USD. Dividing these 2 quantities gives us the above Dexcom EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 20.7x | 16.8x |
| Forward P/E multiples | 17.6x - 21.0x | 19.3x |
| Fair Price | 22.75 - 53.33 | 40.25 |
| Upside | -70.5% - -30.9% | -47.9% |
| Date | EV/EBITDA |
| 2024-12-13 | 37.43 |
| 2024-12-12 | 38.23 |
| 2024-12-11 | 38.93 |
| 2024-12-10 | 38.45 |
| 2024-12-09 | 37.99 |
| 2024-12-06 | 37.67 |
| 2024-12-05 | 38.22 |
| 2024-12-04 | 39.18 |
| 2024-12-03 | 39.13 |
| 2024-12-02 | 38.40 |
| 2024-11-29 | 37.80 |
| 2024-11-27 | 37.85 |
| 2024-11-26 | 37.77 |
| 2024-11-25 | 37.72 |
| 2024-11-22 | 35.44 |
| 2024-11-21 | 36.19 |
| 2024-11-20 | 36.54 |
| 2024-11-19 | 36.38 |
| 2024-11-18 | 37.01 |
| 2024-11-15 | 36.83 |
| 2024-11-14 | 36.29 |
| 2024-11-13 | 35.30 |
| 2024-11-12 | 36.13 |
| 2024-11-11 | 34.29 |
| 2024-11-08 | 34.13 |
| 2024-11-07 | 33.65 |
| 2024-11-06 | 33.52 |
| 2024-11-05 | 33.69 |
| 2024-11-04 | 34.01 |
| 2024-11-01 | 34.31 |
| 2024-10-31 | 34.37 |
| 2024-10-30 | 34.97 |
| 2024-10-29 | 35.17 |
| 2024-10-28 | 35.11 |
| 2024-10-25 | 35.72 |
| 2024-10-24 | 36.36 |
| 2024-10-23 | 35.28 |
| 2024-10-22 | 35.56 |
| 2024-10-21 | 35.34 |
| 2024-10-18 | 35.24 |
| 2024-10-17 | 33.94 |
| 2024-10-16 | 34.10 |
| 2024-10-15 | 32.83 |
| 2024-10-14 | 33.78 |
| 2024-10-11 | 33.79 |
| 2024-10-10 | 33.95 |
| 2024-10-09 | 33.98 |
| 2024-10-08 | 33.89 |
| 2024-10-07 | 33.52 |
| 2024-10-04 | 33.29 |